المؤلفون: Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)

المصدر: Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2044-5385

URL الوصول: https://doaj.org/article/8934e2c0d348469ca8fbc945fd4e9089

المؤلفون: Tiong, Ing Soo, Wall, Meaghan, Marlton, Paula, Johnston, Amanda, Enjeti, Anoop, Fong, Chun Yew, Cull, Gavin, Larsen, Stephen, Kennedy, Glen, Schwarer, Anthony, Kipp, David, Ramanathan, Sundra, Bajel, Ashish, Verner, Emma, Tiley, Campbell, Morris, E, Hahn, U, Moore, J, Taper, J, Purtill, D, Warburton, P, Stevenson, W, Murphy, N, Kalro, Akash, Tan, P, Beligaswatte, A, Mutsando, H, Hertzberg, M, Shortt, J, Szabo, F, Dunne, K, Wei, AH, Australasian Leukaemia and Lymphoma Group (ALLG), Fleming, Shaun, Roberts, Andrew W., Thiagarajah, Nisha, Chua, Chong Chyn, Latimer, Maya, Yeung, David

المساهمون: The University of Newcastle. College of Health, Medicine & Wellbeing, School of Medicine and Public Health

مصطلحات موضوعية: new drug evaluation, real-world outcomes, clinical trials, patients

Relation: Blood Cancer Journal Vol. 14, no. 54; http://hdl.handle.net/1959.13/1501221; uon:55109

الاتاحة: http://hdl.handle.net/1959.13/1501221

المؤلفون: John F. Seymour, David T Yeung, Ilaria S. Pagani, Susan Branford, David M. Ross, Christopher Arthur, Deborah L. White, Anthony K. Mills, Naranie Shanmuganathan, Robin Filshie, Andrew Grigg, Agnes S. M. Yong, Timothy P. Hughes, Chung H. Kok, Verity A Saunders, Jodi Braley, Anthony P. Schwarer, Phuong Dang

المساهمون: Ross, David M, Pagani, Ilaria S, Shanmuganathan, Naranie, Kok, Chung H, White, Deborah L, Branford, Susan, Hughes, Timothy P, Australasian Leukaemia and Lymphoma Group (ALLG)

مصطلحات موضوعية: Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Fusion Proteins, bcr-abl, Antineoplastic Agents, 03 medical and health sciences, Myelogenous, 0302 clinical medicine, chronic myeloid leukemia, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, hemic and lymphatic diseases, medicine, Humans, RNA, Messenger, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Hematology, business.industry, Remission Induction, Myeloid leukemia, Imatinib, Middle Aged, medicine.disease, Long-Term Care, Discontinuation, Leukemia, Imatinib mesylate, Treatment Outcome, 030220 oncology & carcinogenesis, Imatinib Mesylate, Female, business, 030215 immunology, medicine.drug, Chronic myelogenous leukemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d07859e77ae88ea2e1c85ee866a1ca24
https://hdl.handle.net/11541.2/134816